Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The compound of claim 6, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C1-C5 alkyl, wherein the C1-C5 alkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2a substituents;
at least one R2a is C6-C14 aryl, wherein the C6-C14 aryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents;
each R4a is independently halogen or C1-C6 alkyl, wherein each C1-C6 alkyl is optionally and independently substituted by 1, 2, 3, 4, or 5 independently selected R4b substituents; and
each R4b is an independently selected halogen substituent.